Among the companies whose shares are expected to actively trade in Monday's session is Questcor Pharmaceuticals Inc. (QCOR). Questcor Pharmaceuticals said the U.S. Food and Drug Administration extended the date to approve its injectable drug Acthar for the treatment of infantile spasms. The drug company said the extension is to review information regarding labeling and potential post-approval commitments. Shares finished after-hours trading down 8.2% to $9.35. Watch List Fitch Ratings said Tyco Electronics Ltd. (TEL), a maker of electronic components for autos and consumer devices, will probably exceed the ratings agency's original expectations for its performance this fiscal year, raising the likelihood of an upgrade. -By Dow Jones Newswires; write to [email protected] (END) Dow Jones Newswires June 14, 2010 06:21 ET (10:21 GMT)